Comprehensive Assessments of RNA-seq by the SEQC Consortium: FDA-Led Efforts Advance Precision Medicine
Studies on gene expression in response to therapy have led to the discovery of pharmacogenomics biomarkers and advances in precision medicine. Whole transcriptome sequencing (RNA-seq) is an emerging tool for profiling gene expression and has received wide adoption in the biomedical research communit...
Main Authors: | Joshua Xu, Binsheng Gong, Leihong Wu, Shraddha Thakkar, Huixiao Hong, Weida Tong |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4923/8/1/8 |
Similar Items
-
Reproducible inference of transcription factor footprints in ATAC-seq and DNase-seq datasets using protocol-specific bias modeling
by: Aslıhan Karabacak Calviello, et al.
Published: (2019-02-01) -
High concordance between Illumina HiSeq2500 and NextSeq500 for reduced representation bisulfite sequencing (RRBS)
by: Danqing Yin, et al.
Published: (2016-12-01) -
Systematic evaluation of RNA-Seq preparation protocol performance
by: Hsueh-Ping Chao, et al.
Published: (2019-07-01) -
Unipro UGENE NGS pipelines and components for variant calling, RNA-seq and ChIP-seq data analyses
by: Olga Golosova, et al.
Published: (2014-11-01) -
HPRep: Quantifying Reproducibility in HiChIP and PLAC-Seq Datasets
by: Jonathan D. Rosen, et al.
Published: (2021-09-01)